Adicet Bio to Host Conference Call to Provide Updates on its Clinical Pipeline and Corporate Outlook

Rhea-AI Summary

Adicet Bio, Inc. (ACET) to Host Conference Call and Webcast Presentation to Provide Update on Clinical Pipeline and Corporate Outlook

REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)-- Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, today announced that the Company will host a conference call and webcast presentation on Thursday, January 4, 2024 at 8:00am ET to provide an update on its clinical pipeline and corporate outlook.

Conference Call and Webcast Event

The live webcast of the presentation can be accessed by registering under “Presentations & Events” in the investors section of the Company’s website at https://www.adicetbio.com. Upon registration, all participants will receive a confirmation email with a unique passcode to provide access to the webcast event. To participate via telephone, please join by dialing 888-788-0099 (domestic) or 312-626-6799 (international) and referencing the conference ID 918 2940 8885. An archived replay will be available for 30 days following the presentation. The archived webcast will be available on the Company's website beginning approximately two hours after the event.

About Adicet Bio, Inc.

Adicet Bio, Inc. is a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer. Adicet is advancing a pipeline of “off-the-shelf” gamma delta T cells, engineered with chimeric antigen receptors (CARs) to enhance selective tumor targeting and facilitate innate and adaptive immune response for durable activity in patients. For more information, please visit our website at https://www.adicetbio.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240103490668/en/

Adicet Bio, Inc.

Investor and Media Contacts

Anne Bowdidge

abowdidge@adicetbio.com



Janhavi Mohite

Stern Investor Relations, Inc.

212-362-1200

janhavi.mohite@sternir.com

Source: Adicet Bio, Inc.

FAQ

When will Adicet Bio, Inc. (ACET) host the conference call and webcast presentation?

Adicet Bio, Inc. (ACET) will host the conference call and webcast presentation on Thursday, January 4, 2024 at 8:00am ET.

What is the focus of the conference call and webcast presentation?

The focus of the conference call and webcast presentation is to provide an update on Adicet Bio, Inc.'s (ACET) clinical pipeline and corporate outlook.

How can participants access the live webcast of the presentation?

Participants can access the live webcast by registering under 'Presentations & Events' in the investors section of Adicet Bio, Inc.'s (ACET) website at https://www.adicetbio.com.

What are the details for participating via telephone?

To participate via telephone, participants can join by dialing 888-788-0099 (domestic) or 312-626-6799 (international) and referencing the conference ID 918 2940 8885.

Will there be an archived replay available for the presentation?

Yes, an archived replay will be available for 30 days following the presentation, and the webcast will be available on Adicet Bio, Inc.'s (ACET) website approximately two hours after the event.